Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20156712 | 0.93 | CYP4F2 (0.36) | CYP4F2CYP4A11 | |
| SCHEMBL14509111 | 0.78 | SOAT1 (0.36) | CYP4F2CYP4A11 | |
| SCHEMBL18746188 | 0.77 | CYP4F2 (0.31) | CYP4F2CYP4A11 | |
| SCHEMBL22098435 | 0.77 | NAAA (0.48) | CYP4F2CYP4A11 | |
| SCHEMBL12508378 | 0.73 | RECQL (0.34) | — | |
| SCHEMBL28916051 | 0.73 | NAAA (0.48) | — | |
| SCHEMBL14148813 | 0.72 | — | — | |
| SCHEMBL11644752 | 0.71 | TDP1 (0.40) | — | |
| SCHEMBL20081503 | 0.71 | CYP4F2 (0.41) | CYP4F2CYP4A11 | |
| SCHEMBL24831388 | 0.71 | MAPK1 (0.38) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11079675-B2 | Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink | DIC CORPORATION (JP) | 2021-08-03 | — | — | US | disclosed |
| US-20190137872-A1 | NOVEL COMPOUND, PHOTOCURABLE COMPOSITION, CURED PRODUCT OF SAME, PRINTING INK, AND PRINTED MATTER SURING THE PRINTING INK | DIC CORPORATION (JP) | 2019-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11079675-B2 | Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink | EPB41, F12, CDK1 | CYP4F2 2883/4885CYP4A11 885/4885MAPK1 540/4885 |
| US-20190137872-A1 | NOVEL COMPOUND, PHOTOCURABLE COMPOSITION, CURED PRODUCT OF SAME, PRINTING INK, AND PRINTED MATTER SURING THE PRINTING INK | EPB41, CDK1, CDKN1A | CYP4F2 2773/4885CYP4A11 856/4885MAPK1 233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.